Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Burd

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Ebiomedicine|October 4, 2018
Fisetin is a senotherapeutic that extends health and lifespanMatthew J Yousefzadeh, Yi Zhu, Sara J McGowan, et al.
EMBO Molecular Medicine|April 14, 2018
Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanomaIleabett M Echevarría-Vargas, Patricia I Reyes-Uribe, Adam N Guterres, et al.
Molecular Cancer|October 31, 2024
Tumour-intrinsic PDL1 signals regulate the Chk2 DNA damage response in cancer cells and mediate resistance to Chk1 inhibitorsClare E Murray, Anand V R Kornepati, Carlos Ontiveros, et al.
Cell|May 13, 2022
Topical therapy for regression and melanoma prevention of congenital giant neviYeon Sook Choi, Tal H Erlich, Max von Franque, et al.
Nature|May 13, 2021
An aged immune system drives senescence and ageing of solid organsMatthew J Yousefzadeh, Rafael R Flores, Yi Zhu, et al.
Cancer Cell|February 5, 2021
Melanoma models for the next generation of therapiesE Elizabeth Patton, Kristen L Mueller, David J Adams, et al.
Nature|May 24, 2023
Tumour extracellular vesicles and particles induce liver metabolic dysfunctionGang Wang, Jianlong Li, Linda Bojmar, et al.
Redox Biology|May 11, 2018
Spontaneous DNA damage to the nuclear genome promotes senescence, redox imbalance and agingAndria R Robinson, Matthew J Yousefzadeh, Tania A Rozgaja, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Ebiomedicine|October 4, 2018
Fisetin is a senotherapeutic that extends health and lifespanMatthew J Yousefzadeh, Yi Zhu, Sara J McGowan, et al.
EMBO Molecular Medicine|April 14, 2018
Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanomaIleabett M Echevarría-Vargas, Patricia I Reyes-Uribe, Adam N Guterres, et al.
Molecular Cancer|October 31, 2024
Tumour-intrinsic PDL1 signals regulate the Chk2 DNA damage response in cancer cells and mediate resistance to Chk1 inhibitorsClare E Murray, Anand V R Kornepati, Carlos Ontiveros, et al.
Cell|May 13, 2022
Topical therapy for regression and melanoma prevention of congenital giant neviYeon Sook Choi, Tal H Erlich, Max von Franque, et al.
Nature|May 13, 2021
An aged immune system drives senescence and ageing of solid organsMatthew J Yousefzadeh, Rafael R Flores, Yi Zhu, et al.
Cancer Cell|February 5, 2021
Melanoma models for the next generation of therapiesE Elizabeth Patton, Kristen L Mueller, David J Adams, et al.
Nature|May 24, 2023
Tumour extracellular vesicles and particles induce liver metabolic dysfunctionGang Wang, Jianlong Li, Linda Bojmar, et al.
Redox Biology|May 11, 2018
Spontaneous DNA damage to the nuclear genome promotes senescence, redox imbalance and agingAndria R Robinson, Matthew J Yousefzadeh, Tania A Rozgaja, et al.
Pageof 8